Rapid Improvement in Time in Range After the Implementation of an Advanced Hybrid Closed-Loop System in Adolescents and Adults with Type 1 Diabetes

Real-World Performance of the MiniMed™ 780G System: First Report of Outcomes from 4120 Users

“…During 10% of the time, AIT was set at >3 hours while the system is optimized for an AIT of 2-3 hours suggesting that further optimization of settings may have provided even better glycemic outcomes. This is in line with a recently reported cohort of 52 individuals using the MiniMed™ 780G system with optimal settings of 100 mg/dL target and 2 hours AIT, achieving a mean TIR of 79.6±7.9% one month after AHCL initiation 27 .…”

Barriers to Uptake of Insulin Technologies and Novel Solutions

“…The advanced hyperglycemia reduction algorithm administers auto-correction boluses to a fixed glucose target of 120mg/dL. 30 Studies have demonstrated improvement in TIR, improved time in Auto Mode, and improved user experience without increased time in hypoglycemia with use of this system. 30–34 …”

Virtual training on advanced hybrid closed‐loop system MiniMed 780G in a teenager with type 1 diabetes previously treated with multiple daily injections: A case report

“… 6 SmardGuard Auto Mode exits less than one event per week during our study were similar to recently published data on MiniMed 780G in adolescents and adults using a traditional (face to face) training program. 7 …”